TY  - JOUR
AU  - Ruso-Julve, Fulgencio
AU  - Pombero, Ana
AU  - Pilar-Cuéllar, Fuencisla
AU  - García-Díaz, Nuria
AU  - Garcia-Lopez, Raquel
AU  - Juncal-Ruiz, María
AU  - Castro, Elena
AU  - Díaz, Álvaro
AU  - Vazquez-Bourgón, Javier
AU  - García-Blanco, Agustín
AU  - Garro-Martinez, Emilio
AU  - Pisonero, Helena
AU  - Estirado, Alicia
AU  - Ayesa-Arriola, Rosa
AU  - López-Giménez, Juan
AU  - Mayor, Federico
AU  - Valdizán, Elsa
AU  - Meana, Javier
AU  - Gonzalez-Maeso, Javier
AU  - Martínez, Salvador
AU  - Vaqué, José Pedro
AU  - Crespo-Facorro, Benedicto
PY  - 2019
DO  - 10.1038/s41398-019-0647-7
UR  - http://hdl.handle.net/10668/14709
T2  - Translational psychiatry
AB  - A better understanding of the molecular mechanisms that participate in the development and clinical manifestations of schizophrenia can lead to improve our ability to diagnose and treat this disease. Previous data strongly associated the levels of...
LA  - en
KW  - 8-Bromo Cyclic Adenosine Monophosphate
KW  - ADAMTS Proteins
KW  - Animals
KW  - Antipsychotic Agents
KW  - Cells, Cultured
KW  - Cyclic AMP Response Element-Binding Protein
KW  - Dopamine
KW  - Humans
KW  - Leukocytes, Mononuclear
KW  - Mice
KW  - Mitogen-Activated Protein Kinases
KW  - Phosphorylation
KW  - Schizophrenia
KW  - Signal Transduction
TI  - Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics.
TY  - research article
VL  - 9
ER  -